EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC 4.0

Effect of lemborexant on sleep parameters and architecture in adult and elderly participants with mild-to-severe obstructive sleep apnea

Atul Khullar, Mark I Boulos, Michael S B Mak, Margaret Moline, Jocelyn Y Cheng, Nancy Hall

Sleep Medicine · 2025

DOI: 10.1016/j.sleep.2025.106757 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Sleep Medicine, 2025. Verfasst von Atul Khullar und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Alberta, Edmonton, Alberta, Canada; Northern Alberta Sleep Clinic, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Pyridines, Pyrimidines, Orexin Receptor Antagonists. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Institutes of Health Research, Restless Legs Syndrome Foundation, Eisai Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate sleep parameters and architecture in a post hoc analysis of participants with untreated obstructive sleep apnea (OSA) who received lemborexant (LEM) 10 mg (LEM10), a competitive dual orexin-receptor antagonist approved for the treatment of adults with insomnia. METHODS: Study E2006-A001-102 (Study 102; NCT03471871) and Study E2006-A001-113 (Study 113; NCT04647383) were multicenter, randomized, double-blind, placebo (PBO)-controlled, 2-period cross-over studies in participants with mild OSA (apnea-hypopnea index [AHI] ≥5 to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Apnea, ObstructivePyridinesPyrimidinesOrexin Receptor AntagonistsSleepHumansMaleFemaleDouble-Blind MethodMiddle AgedAgedCross-Over StudiesAdultPolysomnographySeverity of Illness IndexTreatment OutcomeSleep Initiation and Maintenance Disorders

Stichwörter der Autor:innen

Dual orexin-receptor antagonistHypnoticsLemborexantObstructive sleep apneaSleep

Substanzen

lemborexantPyridinesPyrimidinesOrexin Receptor Antagonists

Autor:innen und Institutionen

  • University of Alberta, Edmonton, Alberta, Canada; Northern Alberta Sleep Clinic, Edmonton, Alberta, Canada.
  • Department of Medicine, Division of Neurology, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Ontario, Canada; Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook He…
  • Centre for Addiction & Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
  • Eisai Inc., Nutley, NJ, USA. Electronic address: Margaret_Moline@eisai.com.
  • Eisai Inc., Nutley, NJ, USA.

Förderung

  • Canadian Institutes of Health Research
  • Restless Legs Syndrome Foundation
  • Eisai Inc
  • McGill University
  • ResMed
  • Eisai
  • Eisai Canada

Zitieren

APA

Khullar, A., Boulos, M. I., Mak, M. S. B., Moline, M., Cheng, J. Y., & Hall, N. (2025). Effect of lemborexant on sleep parameters and architecture in adult and elderly participants with mild-to-severe obstructive sleep apnea. Sleep Medicine. https://doi.org/10.1016/j.sleep.2025.106757

Vancouver

Khullar A, Boulos MI, Mak MSB, Moline M, Cheng JY, Hall N. Effect of lemborexant on sleep parameters and architecture in adult and elderly participants with mild-to-severe obstructive sleep apnea. Sleep Medicine. 2025. doi:10.1016/j.sleep.2025.106757

BibTeX
@article{Khullar2025,
  author = {Khullar, Atul and Boulos, Mark I and Mak, Michael S B and Moline, Margaret and Cheng, Jocelyn Y and Hall, Nancy},
  title = {Effect of lemborexant on sleep parameters and architecture in adult and elderly participants with mild-to-severe obstructive sleep apnea},
  journal = {Sleep Medicine},
  year = {2025},
  doi = {10.1016/j.sleep.2025.106757}
}
Kostenlos starten →